Free Trial

Amylyx Pharmaceuticals (AMLX) SEC Filings & 10K Form

Amylyx Pharmaceuticals logo
$3.66 -0.21 (-5.43%)
Closing price 03/28/2025 04:00 PM Eastern
Extended Trading
$3.72 +0.06 (+1.75%)
As of 03/28/2025 07:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Amylyx Pharmaceuticals SEC Filings

DateFilerForm TypeView
03/26/2025
11:15 PM
Amylyx Pharmaceuticals (Filer)
Form EFFECT
03/24/2025
3:15 PM
Amylyx Pharmaceuticals (Issuer)
Zeiher Bernhardt G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
7:32 PM
Amylyx Pharmaceuticals (Issuer)
Bedrosian Camille L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
7:34 PM
Amylyx Pharmaceuticals (Issuer)
Mazzariello Gina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
7:28 PM
Amylyx Pharmaceuticals (Issuer)
FRATES JAMES M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
7:28 PM
Amylyx Pharmaceuticals (Issuer)
Cohen Joshua B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
7:30 PM
Amylyx Pharmaceuticals (Issuer)
Klee Justin B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
3:32 PM
Amylyx Pharmaceuticals (Issuer)
Mazzariello Gina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
3:32 PM
Amylyx Pharmaceuticals (Issuer)
Cohen Joshua B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
6:30 AM
Amylyx Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/04/2025
5:24 AM
Amylyx Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/04/2025
5:07 AM
Amylyx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2025
5:14 AM
Amylyx Pharmaceuticals (Filer)
Form POSASR
02/26/2025
3:35 PM
Amylyx Pharmaceuticals (Issuer)
Mazzariello Gina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
3:30 PM
Amylyx Pharmaceuticals (Subject)
Panacea Innovation Ltd (Filed by)
Form SCHEDULE 13G/A
02/06/2025
7:17 PM
Amylyx Pharmaceuticals (Issuer)
Klee Justin B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
3:54 PM
Amylyx Pharmaceuticals (Issuer)
Klee Justin B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
3:55 PM
Amylyx Pharmaceuticals (Issuer)
Cohen Joshua B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
3:58 PM
Amylyx Pharmaceuticals (Issuer)
Mazzariello Gina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/28/2025
3:55 PM
Amylyx Pharmaceuticals (Issuer)
MILNE GEORGE M JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
3:53 PM
Amylyx Pharmaceuticals (Subject)
Point72 Asset Management, L.P. (Filed by)
Form SCHEDULE 13G
01/10/2025
4:13 PM
Amylyx Pharmaceuticals (Filer)
Form 424B5
01/10/2025
4:23 PM
Amylyx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2025
5:05 AM
Amylyx Pharmaceuticals (Filer)
Form 424B5
01/08/2025
4:29 PM
Amylyx Pharmaceuticals (Issuer)
Klee Justin B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
4:26 PM
Amylyx Pharmaceuticals (Issuer)
Cohen Joshua B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/30/2024
6:50 AM
Amylyx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/03/2024
4:21 PM
Amylyx Pharmaceuticals (Issuer)
Bedrosian Camille L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/07/2024
7:22 AM
Amylyx Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2024
6:07 AM
Amylyx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2024
6:24 PM
Amylyx Pharmaceuticals (Issuer)
Klee Justin B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/04/2024
9:56 AM
Amylyx Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G
10/25/2024
4:38 PM
Amylyx Pharmaceuticals (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
Form SC 13G
10/17/2024
8:12 AM
Amylyx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/02/2024
5:48 PM
Amylyx Pharmaceuticals (Issuer)
Mazzariello Gina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2024
5:50 PM
Amylyx Pharmaceuticals (Issuer)
Bedrosian Camille L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2024
5:53 PM
Amylyx Pharmaceuticals (Issuer)
Cohen Joshua B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2024
5:53 PM
Amylyx Pharmaceuticals (Issuer)
Klee Justin B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/25/2024
4:56 PM
Amylyx Pharmaceuticals (Issuer)
Cohen Joshua B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2024
4:39 PM
Amylyx Pharmaceuticals (Issuer)
Cohen Joshua B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2024
4:30 PM
Amylyx Pharmaceuticals (Issuer)
FRATES JAMES M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Trump’s betrayal exposed (Ad)

Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.

Millions of Americans are about to be wiped out, while others could make a fortune… click here to ma
09/05/2024
6:55 PM
Amylyx Pharmaceuticals (Issuer)
FRATES JAMES M (Reporting)
Form 4/A
09/05/2024
6:26 PM
Amylyx Pharmaceuticals (Issuer)
MILNE GEORGE M JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/26/2024
5:49 PM
Amylyx Pharmaceuticals (Subject)
TCG Crossover GP II, LLC (Filed by)
Form SC 13G
08/08/2024
6:09 AM
Amylyx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2024
6:14 AM
Amylyx Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/10/2024
6:09 AM
Amylyx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/08/2024
3:32 PM
Amylyx Pharmaceuticals (Subject)
BlackRock Inc. (Filed by)
Form SC 13G/A
06/21/2024
4:07 PM
Amylyx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/07/2024
3:42 PM
Amylyx Pharmaceuticals (Issuer)
Quimi Daphne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:44 PM
Amylyx Pharmaceuticals (Issuer)
MILNE GEORGE M JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:49 PM
Amylyx Pharmaceuticals (Issuer)
Zeiher Bernhardt G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:50 PM
Amylyx Pharmaceuticals (Issuer)
Firestone Karen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:52 PM
Amylyx Pharmaceuticals (Issuer)
FONTEYNE PAUL R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2024
6:36 PM
Amylyx Pharmaceuticals (Issuer)
Mazzariello Gina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2024
6:37 PM
Amylyx Pharmaceuticals (Issuer)
Quimi Daphne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
6:05 AM
Amylyx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
6:12 AM
Amylyx Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/24/2024
6:12 AM
Amylyx Pharmaceuticals (Filer)
Form DEFA14A
04/24/2024
6:19 AM
Amylyx Pharmaceuticals (Filer)
Form ARS
04/24/2024
6:07 AM
Amylyx Pharmaceuticals (Filer)
Form DEF 14A
04/18/2024
7:19 PM
Amylyx Pharmaceuticals (Issuer)
Bedrosian Camille L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/18/2024
7:20 PM
Amylyx Pharmaceuticals (Issuer)
Klee Justin B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/18/2024
7:20 PM
Amylyx Pharmaceuticals (Issuer)
Mazzariello Gina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/18/2024
7:21 PM
Amylyx Pharmaceuticals (Issuer)
Cohen Joshua B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/18/2024
7:23 PM
Amylyx Pharmaceuticals (Issuer)
FRATES JAMES M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/10/2024
8:19 AM
Amylyx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/04/2024
6:10 AM
Amylyx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:AMLX) was last updated on 3/31/2025 by MarketBeat.com Staff
From Our Partners